Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients

SIMPLE SUMMARY: One of the newest therapies for the treatment of non-small cell lung cancer is immunotherapy targeting the immune checkpoints PD-1 and PD-L1. Factors are now being sought to predict the efficacy of this treatment, as PD-L1 expression on tumor cells is not a perfect indicator. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Grenda, Anna, Iwan, Ewelina, Krawczyk, Paweł, Frąk, Małgorzata, Chmielewska, Izabela, Bomba, Arkadiusz, Giza, Aleksandra, Rolska-Kopińska, Anna, Szczyrek, Michał, Kieszko, Robert, Kucharczyk, Tomasz, Jarosz, Bożena, Wasyl, Dariusz, Milanowski, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777223/
https://www.ncbi.nlm.nih.gov/pubmed/36551735
http://dx.doi.org/10.3390/cancers14246250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777223/
https://www.ncbi.nlm.nih.gov/pubmed/36551735
http://dx.doi.org/10.3390/cancers14246250

Ejemplares similares